Boundless Bio, Inc.
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.55% | -23.61% | -32.22% | -24.43% | -17.75% |
| Total Depreciation and Amortization | 18.02% | 15.97% | 13.48% | 9.27% | 5.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 155.85% | 155.58% | 111.24% | 20.93% | -39.13% |
| Change in Net Operating Assets | 170.65% | -42.34% | -110.01% | -100.00% | -699.12% |
| Cash from Operations | 1.25% | -17.91% | -29.85% | -25.60% | -27.12% |
| Capital Expenditure | 47.36% | -298.73% | -300.63% | -478.71% | -446.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 198.52% | 7.18% | 37.37% | 78.43% | -37.35% |
| Cash from Investing | 191.29% | 2.63% | 31.78% | 73.50% | -42.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.75% | 44,239.52% | 51,093.41% | 52,202.25% | 68,417.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.74% | 19.50% | -71.22% | -415.43% | -1,408.51% |
| Cash from Financing | -99.75% | -6.39% | -8.25% | -11.07% | -11.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -67.43% | -343.82% | -77.46% | 133.16% | -137.72% |